SCHEMBL3026474

SCHEMBL3026474

Nc1nc(-c2ccccc2[N+](=O)[O-])cs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.55
GAA P10253 1/20 0.55
SI P14410 1/20 0.55
MGAM2 Q2M2H8 1/20 0.55
HSD17B10 Q99714 2/20 0.54
MPL P40238 1/20 0.54
MAPT P10636 4/20 0.53
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50
KDM1A O60341 1/20 0.49
RAB9A P51151 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220611 1.00 MGAM (0.55) MGAMGAASIMGAM2HSD17B10
Bromide SCHEMBL8357485 0.98 MAPT (0.55) MGAMGAASIMGAM2HSD17B10
SCHEMBL4755698 0.83 PDE3B (0.51) MGAMGAASIMGAM2HDAC3
SCHEMBL6367549 0.83 HDAC3 (0.49) MGAMGAASIMGAM2HSD17B10
SCHEMBL30294203 0.82 HDAC3 (0.58) MGAMGAASIMGAM2MAPT
SCHEMBL3026473 0.81 HDAC3 (0.51) MGAMGAASIMGAM2HDAC3
SCHEMBL1206979 0.80 EIF4E (0.65) RAB9ASMN1; SMN2NPC1EIF4E
SCHEMBL1915932 0.79 KDM1A (0.60) MGAMGAASIMGAM2MAPT
SCHEMBL9832354 0.77 MGAM (0.59) MGAMGAASIMGAM2SMN1; SMN2
SCHEMBL10806812 0.77 HDAC3 (0.68) MAPTHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119661468-A Dithiazole-containing amide derivative and preparation method and application thereof 遵义医科大学 2025-03-21 CN disclosed
CN-115466229-B Para-amidobenzenesulfonyl compound and application thereof 上海中医药大学 2025-01-24 CN disclosed
CN-115466229-A P-acylamino benzenesulfonyl compound and application thereof 上海中医药大学 2022-12-13 CN disclosed
US-8653278-B2 Isoform selective HDAC inhibitors GEORGETOWN UNIVERSITY (US) 2014-02-18 US disclosed
US-20100196502-A1 Isoform Selective HDAC Inhibitors GEORGETOWN UNIVERSITY (US) 2010-08-05 US disclosed
EP-2049505-A2 ISOFORM-SELECTIVE HDAC INHIBITORS Georgetown University (US) 2009-04-22 EP disclosed
WO-2008019025-A2 ISOFORM-SELECTIVE HDAC INHIBITORS GEORGETOWN UNIVERSITY (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100196502-A1 Isoform Selective HDAC Inhibitors HDAC5, HDAC6, HDAC3 MGAM 4261/4885GAA 343/4885SI 1351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.